Skip to content

Retrospective observational study of the usefulness of Remimazolam in transcatheter aortic valve replacement

Retrospective observational study of the usefulness of Remimazolam in transcatheter aortic valve replacement - Retrospective observational study of the usefulness of Remimazolam in transcatheter aortic valve replacement

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000045195
Enrollment
100
Registered
2021-08-20
Start date
2021-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic valve stenosis

Interventions

None listed

Sponsors

Kindai University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent transcatheter aortic valve implantation at Kindai University Hospital during the study period.

Exclusion criteria

Exclusion criteria: Patients who cannot obtain their consent

Design outcomes

Primary

MeasureTime frame
Time required for awakening

Secondary

MeasureTime frame
Hemodynamics during anesthesia Procedure success rate of TAVI Postoperative cognitive function

Countries

Japan

Contacts

Public ContactAtsuhiro Kitaura

Kindai University Faculty of Medicine Department of Anesthesiology and Critical Care

anesth@med.kindai.ac.jp0723660221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026